These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20553953)

  • 1. The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain.
    Zhao J; Pan HL; Li TT; Zhang YQ; Wei JY; Zhao ZQ
    Life Sci; 2010 Jul; 87(3-4):120-5. PubMed ID: 20553953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
    Pan HL; Liu BL; Lin W; Zhang YQ
    Neurosci Bull; 2016 Oct; 32(5):445-54. PubMed ID: 27631681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice.
    Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H
    Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.
    Pan HL; Zhang YQ; Zhao ZQ
    Mol Pain; 2010 Dec; 6():85. PubMed ID: 21118579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.
    Uchida H; Matsumoto M; Ueda H
    Neurochem Int; 2009; 54(3-4):215-21. PubMed ID: 19111589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP and cGMP-dependent protein kinase I pathway in dorsal root ganglia contributes to bone cancer pain in rats.
    Liu S; Zhang MY; Chen LP; Liu YP; Liu GJ
    Spine (Phila Pa 1976); 2014 Sep; 39(19):1533-41. PubMed ID: 24921837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid as the initiator of neuropathic pain.
    Ueda H
    Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
    Chen J; Wang L; Zhang Y; Yang J
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):367-72. PubMed ID: 22349022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain.
    Li Y; Cai J; Han Y; Xiao X; Meng XL; Su L; Liu FY; Xing GG; Wan Y
    Eur J Pain; 2014 Jul; 18(6):774-84. PubMed ID: 24827675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced SCN7A/Nax expression contributes to bone cancer pain by increasing excitability of neurons in dorsal root ganglion.
    Ke CB; He WS; Li CJ; Shi D; Gao F; Tian YK
    Neuroscience; 2012 Dec; 227():80-9. PubMed ID: 23026072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats.
    Wu JX; Yuan XM; Wang Q; Wei W; Xu MY
    Mol Pain; 2016; 12():. PubMed ID: 27094551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA
    Szepanowski F; Szepanowski LP; Mausberg AK; Kleinschnitz C; Kieseier BC; Stettner M
    Neurosci Lett; 2018 Jan; 662():136-141. PubMed ID: 29051083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of acid-sensing ion channel 3 within dorsal root ganglia in a rat model of bone cancer pain.
    Qiu F; Wei X; Zhang S; Yuan W; Mi W
    Neuroreport; 2014 Aug; 25(12):887-93. PubMed ID: 25006846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 within dorsal root ganglia in a rat model of bone cancer pain.
    Qiu F; Jiang Y; Zhang H; Liu Y; Mi W
    Neurosci Lett; 2012 Mar; 512(2):61-6. PubMed ID: 22342308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of TRESK channels by the inflammatory mediator lysophosphatidic acid balances nociceptive signalling.
    Kollert S; Dombert B; Döring F; Wischmeyer E
    Sci Rep; 2015 Jul; 5():12548. PubMed ID: 26224542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.
    Inoue M; Rashid MH; Fujita R; Contos JJ; Chun J; Ueda H
    Nat Med; 2004 Jul; 10(7):712-8. PubMed ID: 15195086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.
    Inoue M; Yamaguchi A; Kawakami M; Chun J; Ueda H
    Mol Pain; 2006 Aug; 2():25. PubMed ID: 16914035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor modulates N-methyl-D-aspartate receptor activation in a rat model of cancer-induced bone pain.
    Wang LN; Yang JP; Ji FH; Zhan Y; Jin XH; Xu QN; Wang XY; Zuo JL
    J Neurosci Res; 2012 Jun; 90(6):1249-60. PubMed ID: 22354476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.